Insider Transactions in Q1 2023 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
100
-0.51%
|
$2,200
$22.01 P/Share
|
|
Mar 15
2023
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.51%
|
$100
$1.24 P/Share
|
|
Feb 14
2023
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
10,000
-17.47%
|
$230,000
$23.93 P/Share
|
|
Feb 14
2023
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.43%
|
$10,000
$1.24 P/Share
|
|
Feb 03
2023
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
3,221
-5.69%
|
$77,304
$24.26 P/Share
|
|
Feb 03
2023
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,221
+5.39%
|
$3,221
$1.24 P/Share
|
|
Feb 02
2023
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
45,879
-46.23%
|
$1,101,096
$24.36 P/Share
|
|
Feb 02
2023
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,879
+31.62%
|
$45,879
$1.24 P/Share
|
|
Feb 01
2023
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
900
-1.66%
|
$21,600
$24.27 P/Share
|
|
Feb 01
2023
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+1.63%
|
$900
$1.24 P/Share
|
|
Jan 20
2023
|
W. Michael Flanagan CSTO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+49.82%
|
-
|
|
Jan 20
2023
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.38%
|
-
|
|
Jan 20
2023
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+48.83%
|
-
|
|
Jan 20
2023
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,500
+45.85%
|
-
|
|
Jan 20
2023
|
Arthur A Levin Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+48.22%
|
-
|
|
Jan 12
2023
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
10,000
-88.26%
|
$220,000
$22.0 P/Share
|
|
Jan 12
2023
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+46.88%
|
$10,000
$1.24 P/Share
|